RT Journal Article
SR Electronic
T1 737 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastatic solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A830
OP A830
DO 10.1136/jitc-2023-SITC2023.0737
VO 11
IS Suppl 1
A1 Moser, Justin C
A1 Opyrchal, Mateusz
A1 Rivera, Ildefonso Rodriguez
A1 Bilen, Mehmet A
A1 Curti, Brendan
A1 Puzanov, Igor
A1 Morris, Kristin
A1 Nirschl, Christopher J
A1 Park, Saero
A1 Bruno, Marissa
A1 Windt, Paul
A1 Subramanian, Kulandayan K
A1 Chopra, Sameer S
A1 Isaacs, Randi
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A830.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.